1st Mentored Paper Initiative (Fall 2020)

Topics

MPI1.1: Is possible to grow cellulose layers of controllable porosity at home?

 

MPI1.2: There are many naturally occurring chemicals that exhibit semiconducting properties (e.g. the dye in berries) and therefore can be used in devices such as solar cells. What do we know about such materials and can we find any new uses for them as semiconductors?

 

MPI1.3: What is the importance of resistance exercise training for older adults?

 

MPI1.4: What is the dose-response of muscle protein synthesis to whey protein ingestion at rest and after resistance exercise in middle-age adults?

 

MPI1.5: What is the effect of mHealth interventions compared to usual care on glycemic control in women with diabetes during pregnancy (T1D, T2D, GDM)?

 

MPI1.6: What effects do physical activity and exercise have on leptin levels and adiposity?

 

MPI1.7: What effects do physical activity and exercise have on depression and inflammation?

 

MPI1.8: What is the influence of menstrual cycle conditions (ex. amenorrhea, polycystic ovarian syndrome (PCOS)) on cardiovascular outcomes?

 

MPI1.9: What current therapies currently exist for the treatment of schizophrenia?

 

MPI1.10: What is known about the pathogenesis of major depressive disorders?

 

MPI1.11: What is the role of digital technology in chronic disease management?

 

MPI1.12: What inequities may be perpetuated through the increased use of digital health platforms?

 

MPI1.13: Are there decreases in health app usage overtime? What factors might be contributing to these decreases?

 

MPI1.14: What are strategies for new cancer therapeutics? How do emerging cancer therapeutics compare to those currently available?

 

MPI1.15: What are proposed models for the genesis of functional heterogeneity in cancer and what are strategies for targeting cancer stem cells?

 

MPI1.16: To what extent is the nucleus reuniens inovled in the memory generalization?

 

MPI1.17: How does neurogenesis mediate inaccessibility of memories?

 

MPI1.18: It has been shown that women having birthed 5 or more children are at a higher risk of developing Alzheimer's disease. What is the relationship between reproductive history and Alzheimer incidence?

 

MPI1.19: Nanoparticle drug delivery is a popular area of study at the moment. What nanoparticle characteristics are ideal when developing drug delivery systems to the human placenta? Do any current nanoparticle designs meet that criteria?